<DOC>
	<DOCNO>NCT01873859</DOCNO>
	<brief_summary>The purpose study determine whether metformin cause lactic acidosis diabetic patient preserve kidney function , undergo coronary angiography angioplasty new contrast medium . In word necessary discontinue metformin procedure , even Iodixanol use contrast medium , isosmolar agent much safe urografin main agent previous study base present guideline ?</brief_summary>
	<brief_title>Safety Continuing Metformin Diabetic Patients With Normal Kidney Function Receiving Contrast Media</brief_title>
	<detailed_description>Although metformin directly nephrotoxic , postulate impair gluconeogenesis lactate , may lead lactate accumulation circumstance acute renal failure . In diabetic patient receive metformin , condition encounter set acute renal failure follow contrast medium administration , coronary angiography i.e . contrast-induced nephropathy . As result , part routine clinical practice discontinue metformin angiography prevent metformin-associated lactic acidosis ( MALA ) . However , general consensus regard incidence MALA evidence intervention poor . On hand , discontinuation metformin associate detrimental effect glycemic control thereby may increase cardiovascular risk diabetic patient undergo percutaneous coronary intervention . Consequently , question raise recently regard routine discontinuation metformin , low-risk patient undergo coronary angiography . The present study design assess role metformin lactate production group diabetic patient normal renal function ; address question significance routine discontinuation metformin low risk patient undergo coronary angiography . Iodixanol contrast medium patient , low nephrotoxicity . Serum blood urea nitrogen creatinin ; well arterial blood gas evaluate prior angiography , repeat 24 48 hour procedure . Glomerular filtration rate ( GFR ) calculate use Cockcroft-Gault formula { GFR= 0.85 ( woman ) } . Contrast-induced acute kidney injury define 25-50 % 0.3-0.5 mg/dl net increase creatinine concentration compare baseline value . Metformin-associated lactic acidosis ( MALA ) define arterial pH ( potential hydrogen ) &lt; 7.35 plasma lactate concentration &gt; 5 mmol‚ÅÑL . In M ( - ) group metformin re-started 48 hour angiography , albeit absence evidence lactic acidosis GFR &gt; 60 mL/min per 1.73 m2 . A write informed consent take participant institutional review board already approve trial .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Acidosis</mesh_term>
	<mesh_term>Acidosis , Lactic</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Diabetic patient receive metformin schedule : coronary angiography coronary angioplasty Patients contraindication metformin administration , : decompensated heart failure severe liver disease severe hypoxemia GFR &lt; 60 mL/min per 1.73 m2</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Lactic acidosis</keyword>
	<keyword>Contrast medium</keyword>
	<keyword>Angiography</keyword>
	<keyword>Diabetic</keyword>
	<keyword>Metformin</keyword>
</DOC>